Followers | 1 |
Posts | 70 |
Boards Moderated | 0 |
Alias Born | 02/27/2019 |
Friday, March 13, 2020 11:35:16 AM
You're alluding to EXDI being in a cash crunch, but that is not a given. Granted, it had almost no cash at 09/30/2019, but the plan was to monetize the 2019 harvest in Q4/'19 and Q1/'20. In addition to their own harvested biomass, they had inventory for sale from Ceed2Med from orders placed and paid to C2M earlier in 2019.
In addition, if cash is indeed an issue, they could always go to their "friends and family". See: https://www.globenewswire.com/news-release/2019/05/29/1856602/0/en/Exactus-Inc-to-Present-at-the-9th-Annual-LD-Micro-Invitational.html
"the Company has built a tremendous foundation that includes raising over $4 million through friends and family"
We will have to see: I'm inclined to give the optimists the benefit of the doubt here, but you have been more often right than not. However, if cash turns out to be an issue, there will be serious questions as to "why?","how?", "where?", etc., related to the concerns of whether this is a legitimate business or a scam.
Recent PLSH News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 03:28:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 07:24:23 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/08/2023 08:04:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 05:07:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 01:15:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2023 04:21:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2023 03:28:18 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 03:19:11 PM
- Panacea Life Sciences Holdings, Inc. Chief Scientific Officer, Dr. James Baumgartner, is Featured on The Stock Day Podcast • InvestorsHub NewsWire • 07/18/2023 04:41:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 01:00:13 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM